| http://dbpedia.org/ontology/abstract
|
Oxogestone phenpropionate (OPP; USAN) (for … Oxogestone phenpropionate (OPP; USAN) (former developmental code name or tentative brand name Oxageston), also known as xinogestone, as well as 20β-hydroxy-19-norprogesterone 20β-(3-phenylpropionate), is a progestin related to the 19-norprogesterone derivatives which was developed as an injectable hormonal contraceptive, specifically a progestogen-only injectable contraceptive, in the 1960s and early 1970s but was never marketed. It was studied at a dose of 50 to 75 mg once a month by intramuscular injection but was associated with a high failure rate with this regimen and was not further developed. OPP is the 20β-(3-phenylpropionate) ester of oxogestone, which, similarly, was never marketed.one, which, similarly, was never marketed.
|
| http://dbpedia.org/ontology/casNumber
|
16915-80-3
|
| http://dbpedia.org/ontology/chEMBL
|
2107303
|
| http://dbpedia.org/ontology/class
|
http://dbpedia.org/resource/Progestogen_ester +
, http://dbpedia.org/resource/Progestogen +
|
| http://dbpedia.org/ontology/fdaUniiCode
|
7IA4J676HM
|
| http://dbpedia.org/ontology/kegg
|
D05308
|
| http://dbpedia.org/ontology/pubchem
|
20055360
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/Oxogestone_phenpropionate.svg?width=300 +
|
| http://dbpedia.org/ontology/wikiPageID
|
51055369
|
| http://dbpedia.org/ontology/wikiPageLength
|
5124
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
992120901
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Oxogestone +
, http://dbpedia.org/resource/Progestin +
, http://dbpedia.org/resource/Progestogen_ester +
, http://dbpedia.org/resource/Category:Phenylpropionate_esters +
, http://dbpedia.org/resource/Category:Hormonal_contraception +
, http://dbpedia.org/resource/Hormonal_contraceptive +
, http://dbpedia.org/resource/Ester +
, http://dbpedia.org/resource/Progestogen-only_injectable_contraceptive +
, http://dbpedia.org/resource/Phenylpropanoic_acid +
, http://dbpedia.org/resource/Progestogen +
, http://dbpedia.org/resource/Category:Norpregnanes +
, http://dbpedia.org/resource/19-norprogesterone +
, http://dbpedia.org/resource/List_of_progestogen_esters +
, http://dbpedia.org/resource/Category:Progestogen_esters +
, http://dbpedia.org/resource/Category:Abandoned_drugs +
, http://dbpedia.org/resource/Injection_%28medicine%29 +
, http://dbpedia.org/resource/Category:Progestogens +
, http://dbpedia.org/resource/Intramuscular_injection +
|
| http://dbpedia.org/property/c
|
29
|
| http://dbpedia.org/property/casNumber
|
16915
|
| http://dbpedia.org/property/chembl
|
2107303
|
| http://dbpedia.org/property/chemspiderid
|
16736681
|
| http://dbpedia.org/property/class
|
http://dbpedia.org/resource/Progestogen +
, http://dbpedia.org/resource/Progestogen_ester +
|
| http://dbpedia.org/property/h
|
38
|
| http://dbpedia.org/property/iupacName
|
[-1-[-13-methyl-3-oxo-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethyl] 3-phenylpropanoate
|
| http://dbpedia.org/property/kegg
|
D05308
|
| http://dbpedia.org/property/o
|
3
|
| http://dbpedia.org/property/pubchem
|
20055360
|
| http://dbpedia.org/property/routesOfAdministration
|
http://dbpedia.org/resource/Intramuscular_injection +
|
| http://dbpedia.org/property/smiles
|
CCOCCCC5=CC=CC=C5
|
| http://dbpedia.org/property/stdinchi
|
1
|
| http://dbpedia.org/property/stdinchikey
|
LHPBUFXEIOLURH-GQZONRFDSA-N
|
| http://dbpedia.org/property/synonyms
|
Oxogesterone phenpropionate; Xinogestone; Oxageston; 20β-Hydroxy-19-norprogesterone phenylpropionate; 20β-Dihydro-19-norprogesterone 20β-; 20β-Hydroxy-19-norpregn-4-en-3-one 20β-; -3-Oxo-19-norpregn-4-en-20-yl 3-phenylpropanoate
|
| http://dbpedia.org/property/unii
|
7
|
| http://dbpedia.org/property/width
|
250
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Abbrlink +
, http://dbpedia.org/resource/Template:Steroid-stub +
, http://dbpedia.org/resource/Template:Genito-urinary-drug-stub +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Progesterone_receptor_modulators +
, http://dbpedia.org/resource/Template:Parenteral_potencies_and_durations_of_progestogens +
, http://dbpedia.org/resource/Template:Drugbox +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Abandoned_drugs +
, http://dbpedia.org/resource/Category:Phenylpropionate_esters +
, http://dbpedia.org/resource/Category:Hormonal_contraception +
, http://dbpedia.org/resource/Category:Progestogens +
, http://dbpedia.org/resource/Category:Norpregnanes +
, http://dbpedia.org/resource/Category:Progestogen_esters +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Oxogestone_phenpropionate?oldid=992120901&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/Oxogestone_phenpropionate.svg +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Oxogestone_phenpropionate +
|
| owl:sameAs |
https://global.dbpedia.org/id/2YGzb +
, http://www.wikidata.org/entity/Q27268344 +
, http://dbpedia.org/resource/Oxogestone_phenpropionate +
, http://yago-knowledge.org/resource/Oxogestone_phenpropionate +
|
| rdf:type |
http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#ChemicalObject +
, http://www.wikidata.org/entity/Q8386 +
, http://dbpedia.org/ontology/Drug +
, http://dbpedia.org/ontology/ChemicalSubstance +
|
| rdfs:comment |
Oxogestone phenpropionate (OPP; USAN) (for … Oxogestone phenpropionate (OPP; USAN) (former developmental code name or tentative brand name Oxageston), also known as xinogestone, as well as 20β-hydroxy-19-norprogesterone 20β-(3-phenylpropionate), is a progestin related to the 19-norprogesterone derivatives which was developed as an injectable hormonal contraceptive, specifically a progestogen-only injectable contraceptive, in the 1960s and early 1970s but was never marketed. It was studied at a dose of 50 to 75 mg once a month by intramuscular injection but was associated with a high failure rate with this regimen and was not further developed. OPP is the 20β-(3-phenylpropionate) ester of oxogestone, which, similarly, was never marketed.one, which, similarly, was never marketed.
|
| rdfs:label |
Oxogestone phenpropionate
|
